• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

Erucic acid Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5751345

Increased levels of erucic acid (22:1n9) have been found in the red blood cell membranes of autistic subjects with developmental regression (PMID: 16581239). Erucic acid is broken down long-chain acyl-coenzyme A (CoA) dehydrogenase, which is produced in the… More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
Erucic acid, Inhibitor
Full Product Name
Erucic acid
Product Synonym Names
cis-13-docosenoic acid; 13(Z)-Docosenoic Acid; Prifac 2990
Form/Format
Powder
Purity/Purification
98.00%
Preparation and Storage
Store at -20 degree C for 3 years powder; -80 degree C for 2 years in solvent
For obtaining a higher solubility, please warm the tube at 37 degree C and shake it in the ultrasonic bath for a while. Stock solution can be stored below -20 degree C for several month.
Molecular Weight
338.57
Formula
C22H42O2
CAS
112-86-7
Smiles
CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O
Solubility
Water: Soluble
ethanol: 1750mg/mL
(<1mg/ml refers to the product slightly soluble or insoluble)

Product Categories/Family for Erucic acid, inhibitor

Product References and Citations for Erucic acid, inhibitor

1. Aubourg P, Adamsbaum C, Lavallardrousseau M C, et al. A two-year trial of oleic and erucic acids ("Lorenzo's oil") as treatment for adrenomyeloneuropathy.[J]. New England Journal of Medicine, 1993, 329 (11):745.
2. Brown D G, Rao S, Weir T L, et al. Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool[J]. Cancer & Metabolism, 2016, 4 (1):11.
3. Dercksen M, Kulik W, Mienie L J, et al. Polyunsaturated fatty acid status in treated isovaleric acidemia patients[J]. European Journal of Clinical Nutrition, 2016, 70 (10).
4. Bu B, Ashwood P, Harvey D, et al. Fatty acid compositions of red blood cell phospholipids in children with autism[J]. Prostagrandins Leukot Essent Fatty Acids, 2006, 74 (4):215-221.
5. Rizzo W B, Leshner R T, Odone A, et al. Dietary erucic acid therapy for X?linked adrenoleukodystrophy[J]. Neurology, 1989, 39 (11):1415-1422.
6. Kim E, et al. The memory-enhancing effect of erucic acid on scopolamine-induced cognitive impairment in mice. Pharmacol Biochem Behav. 2016 Mar;142:85-90.

Other Notes

Small volumes of Erucic acid, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for Erucic acid purchase

MBS5751345 is an inhibitor targeting Erucic acid.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000